TRU

What Every Investor Must Know About TRU Stock

We've been asking ourselves recently if the market has placed a fair valuation on TransUnion. Let's dive into some of the fundamental values of this Large-Cap Finance company to determine if there might be an opportunity here for value-minded investors.

TransUnion's Valuation Is in Line With Its Sector Averages:

TransUnion operates as a global consumer credit reporting agency that provides risk and information solutions. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 12.38 and an average price to book (P/B) ratio of 1.58. In contrast, TransUnion has a trailing 12 month P/E ratio of -76.3 and a P/B ratio of 3.91.

TransUnion's PEG ratio is 2.63, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Increasing Revenues but Narrowing Margins:

2018 2019 2020 2021 2022 2023
Revenue (M) $2,317 $2,463 $2,531 $2,960 $3,710 $3,779
Interest Income (M) $138 $174 $126 $113 $231 $285
Operating Margins 22% 22% 20% 22% 17% 3%
Net Margins 12% 14% 14% 47% 7% -7%
Net Income (M) $277 $347 $343 $1,387 $270 -$247
Depreciation & Amort. (M) $307 $339 $347 $377 $519 $521
Diluted Shares (M) 803 606 455 343 257 193
Earnings Per Share $0.34 $0.57 $0.75 $4.04 $1.05 -$1.28
EPS Growth n/a 67.65% 31.58% 438.67% -74.01% -221.9%
Avg. Price $64.33 $72.42 $84.9 $105.82 $92.65 $80.09
P/E Ratio 178.69 122.75 110.26 25.87 88.24 -62.57
CAPEX (M) $180 $188 $206 $224 $298 $319
EV / EBITDA 65.47 52.22 48.38 39.52 25.14 23.26
Total Debt (M) $4,120 $3,716 $3,510 $6,480 $5,785 $115
Net Debt / EBITDA 4.8 3.91 3.56 4.53 4.52 -0.47
Current Ratio 1.53 1.55 2.19 1.94 1.6 1.54

TransUnion has rapidly growing revenues and increasing reinvestment in the business, low leverage levels, and a decent current ratio of 1.54. However, the firm suffers from weak operating margins with a negative growth trend and declining EPS growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS